Everyday treatment strategies of non ST-segment elevation acute coronary syndromes in hospitals without on-site invasive facility - The Malopolska Registry;Codzienna praktyka kliniczna w ostrych zespołach wieńcowych bez uniesienia odcinka ST w szpitalach rejonowych - Rejestr w Małopolsce

Folia Cardiologica

Volumn 12, Issue 1, 2005, Pages 21-31

  Siudak, Zbigniew ^a   Dudek, Dariusz ^a   Kuta, Marcin ^b   Mielecki, Waldemar ^a   Rakowski, Tomasz ^a   Dziewierz, Artur ^a   Dubiel, Jacek S ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b Specjalistyczny Szpital E Szczeklika   (Poland)

Author keywords

Acute coronary syndrome; Non ST segment elevation acute coronary syndrome; Percutaneous coronary intervention; TIMI risk score

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; PYRIDINE DERIVATIVE; TROPONIN I; TROPONIN T;

ACUTE DISEASE; ANGIOCARDIOGRAPHY; ARTICLE; COMMUNITY HOSPITAL; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CLASSIFICATION; FREQUENCY ANALYSIS; HEALTH CARE FACILITY; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PATIENT TRANSPORT; POLAND; REGISTER; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 14644421502     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hasdai D., Behar S., Wallentin L. i wsp. A prospective survey of the characteristics, treatments and outcomes in patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (ACS). Eur. Heart J. 2002; 23: 1190-1201.
2. Steg P.G., Goldberg R.J., Gore J.M. i wsp. Baseline Characteristics, Management Practices, and In-Hospital Outcomes of Patients Hospitalised With Acute Coronary Syndromes in the Global Registry of Acute Coronary Events (GRACE). Am. J. Cardiol. 2002; 90: 358-363.
3. Fox K.A., Cokkinos D.V., Deckers J., Keil U., Maggioni A., Steg G. The ENACT study: a pan-European survey of acute coronary syndromes. Eur. Heart J. 2000; 21: 1440-1449.
4. Bertrand M.E., Simoons M.L., Fox K.A. i wsp. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur. Heart J. 2002; 23: 1809-1840.
5. Kennon S., Suliman A., MacCallum P.K., Ranjadayalan K., Wilkinson P., Timmis A.D. Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 1998; 32: 2018-2022.
6. Anderson H.V., Gibson R.S., Stone P.H. i wsp. Management of unstable angina and non-Q wave myocardial infarction in the United States and Canada (the TIMI III Registry). Am. J. Cardiol. 1997; 79: 1441-1446.
7. Yusuf S., Flather M., Pogue J. i wsp. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1998; 352: 507-514.8.
8. Collinson J., Flather M.D., Fox K.A.A. i wsp. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur. Heart J. 2000; 21: 1450-1457.
9. The Grace Investigators. Rationale and design of the GRACE (Global registry of Acute Coronary Events) project: a multinational registry of patients hospitalised with acute coronary syndromes. Am. Heart J. 2001; 141: 190-199.
10. Granger C.B. Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry. Am. J. Cardiol. 2000; 86: 4M-9M.
11. Prasad A., Mathew V., Holmes D.R., Gersh BJ. Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials. Eur. Heart J. 2003; 24: 1544-1553.
12. Shamiss Y., Khaykin Y., Papastergiou J. i wsp. Risk stratification, management and outcomes of patients with non-ST elevation acute coronary syndrome: a Canadian teaching hospital perspective. Can. J. Cardiol. 2003; 19: 1033-1039.
13. Breeman A., Mercado N., Lenzen M. i wsp. PURSUIT Investigators. Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy). Cardiology 2002; 98: 195-201.
14. Ferreiros E.R., Kevorkian R., Fuselli J.J. i wsp. First national survey on management strategies in non ST-elevation acute ischaemic syndromes in Argentina. Results of the STRATEG-SIA study. Eur. Heart J. 2002; 23: 1021-1029.
15. Bertrand M.E., Simoons M.L., Fox K.A. i wsp. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology. Eur. Heart J. 2000; 21: 1406-1432.
16. Dudek D., Siudak Z., Kuta M. i wsp. Charakterystyka kliniczna oraz leczenie u pacjentów z ostrymi zespołami wieńcowymi w szpitalach bez pracowni kardiologii inwazyjnej. Małopolski Rejestr Ostrych Zespołów Wieńcowych 2002-2003 (praca w recenzji).
17. Antman E.M., Cohen M., Bernink P.J. i wsp. The TIMI Risk Score for Unstable Angina/Non-ST Elevation MI. A Method for Prognostication and Therapeutic Decision Making. JAMA 2000; 284: 835-842.
18. Fox K.A., Mehta S.R., Peters R. i wsp. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004; 110: 1202-1208.
19. Steinhubl S.R., Berger P.B., Mann J.T. 3rd i wsp. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411-2420.
20. Braunwald E., Antman E.M., Beaseley J.W. i wsp. ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction - 2002: Summary Article. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002; 106: 1893-1900.
21. Cannon C.P., Weintraub W.S., Demopoulos L.A. i wsp. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIA inhibitor tirofiban. N. Eng. J. Med. 2001; 344: 1879-1887.
22. Ronner E., Boersma E., Laarman G.J. i wsp. Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy. J. Am. Coll. Cardiol. 2002; 39: 1924-1929.
23. Ronner E., Boersma E., Akkerhuis K.M. i wsp. Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur. Heart J. 2002; 23: 239-246.
24. Morrow D.A., Antman E.M., Snapinn S.M. McCabe Ch., Theroux P., Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISMPLUS. Eur. Heart J. 2002; 23: 223-229.
25. Wallentin L., Lagerqvist B., Husted S., Kontny F., Stahle E., Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary artery disease: the FRISC II invasive randomised trial. Lancet 2000; 356: 9-16.
26. Fox K.A., Poole-Wilson P.A., Henderson R.A. i wsp. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002; 360: 743-751.
27. Popma J.J., Suk J. Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction. Am. J. Cardiol. 2001; 88: 25K-29K.
28. Dudek D., Chyrchel M., Legutko J. i wsp. Outcomes of patients presenting with acute coronary syndromes and negative Troponin-T. Int. J. Cardiol. 2003; 88: 49-55.
29. Heidenreich P.A., Alloggiamento T., Melsop K., McDonald K.M., Go A.S., Hlatky M.A. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J. Am. Coll. Cardiol. 2001; 38: 478-485.